List of Tables
Table 1. Global Cytomegalovirus Infection Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Cidofovir
Table 3. Key Players of Foscarnet
Table 4. Key Players of Valganciclovir
Table 5. Key Players of Ganciclovir
Table 6. Global Cytomegalovirus Infection Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Cytomegalovirus Infection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Cytomegalovirus Infection Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Cytomegalovirus Infection Market Share by Region (2018-2023)
Table 10. Global Cytomegalovirus Infection Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Cytomegalovirus Infection Market Share by Region (2024-2029)
Table 12. Cytomegalovirus Infection Market Trends
Table 13. Cytomegalovirus Infection Market Drivers
Table 14. Cytomegalovirus Infection Market Challenges
Table 15. Cytomegalovirus Infection Market Restraints
Table 16. Global Cytomegalovirus Infection Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Cytomegalovirus Infection Market Share by Players (2018-2023)
Table 18. Global Top Cytomegalovirus Infection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cytomegalovirus Infection as of 2022)
Table 19. Ranking of Global Top Cytomegalovirus Infection Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Cytomegalovirus Infection Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Cytomegalovirus Infection Product Solution and Service
Table 23. Date of Enter into Cytomegalovirus Infection Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cytomegalovirus Infection Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Cytomegalovirus Infection Revenue Market Share by Type (2018-2023)
Table 27. Global Cytomegalovirus Infection Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Cytomegalovirus Infection Revenue Market Share by Type (2024-2029)
Table 29. Global Cytomegalovirus Infection Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Cytomegalovirus Infection Revenue Market Share by Application (2018-2023)
Table 31. Global Cytomegalovirus Infection Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Cytomegalovirus Infection Revenue Market Share by Application (2024-2029)
Table 33. North America Cytomegalovirus Infection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Cytomegalovirus Infection Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Cytomegalovirus Infection Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Cytomegalovirus Infection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Cytomegalovirus Infection Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Cytomegalovirus Infection Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Cytomegalovirus Infection Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Cytomegalovirus Infection Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Cytomegalovirus Infection Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Cytomegalovirus Infection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Cytomegalovirus Infection Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Cytomegalovirus Infection Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Cytomegalovirus Infection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Cytomegalovirus Infection Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Cytomegalovirus Infection Market Size by Country (2024-2029) & (US$ Million)
Table 48. Roche Company Detail
Table 49. Roche Business Overview
Table 50. Roche Cytomegalovirus Infection Product
Table 51. Roche Revenue in Cytomegalovirus Infection Business (2018-2023) & (US$ Million)
Table 52. Roche Recent Development
Table 53. GlaxoSmithKline Company Detail
Table 54. GlaxoSmithKline Business Overview
Table 55. GlaxoSmithKline Cytomegalovirus Infection Product
Table 56. GlaxoSmithKline Revenue in Cytomegalovirus Infection Business (2018-2023) & (US$ Million)
Table 57. GlaxoSmithKline Recent Development
Table 58. Vical Company Detail
Table 59. Vical Business Overview
Table 60. Vical Cytomegalovirus Infection Product
Table 61. Vical Revenue in Cytomegalovirus Infection Business (2018-2023) & (US$ Million)
Table 62. Vical Recent Development
Table 63. AiCuris Anti-Infective Cures Company Detail
Table 64. AiCuris Anti-Infective Cures Business Overview
Table 65. AiCuris Anti-Infective Cures Cytomegalovirus Infection Product
Table 66. AiCuris Anti-Infective Cures Revenue in Cytomegalovirus Infection Business (2018-2023) & (US$ Million)
Table 67. AiCuris Anti-Infective Cures Recent Development
Table 68. ViroPharma Company Detail
Table 69. ViroPharma Business Overview
Table 70. ViroPharma Cytomegalovirus Infection Product
Table 71. ViroPharma Revenue in Cytomegalovirus Infection Business (2018-2023) & (US$ Million)
Table 72. ViroPharma Recent Development
Table 73. Chimerix Company Detail
Table 74. Chimerix Business Overview
Table 75. Chimerix Cytomegalovirus Infection Product
Table 76. Chimerix Revenue in Cytomegalovirus Infection Business (2018-2023) & (US$ Million)
Table 77. Chimerix Recent Development
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cytomegalovirus Infection Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Cytomegalovirus Infection Market Share by Type: 2022 VS 2029
Figure 3. Cidofovir Features
Figure 4. Foscarnet Features
Figure 5. Valganciclovir Features
Figure 6. Ganciclovir Features
Figure 7. Global Cytomegalovirus Infection Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Cytomegalovirus Infection Market Share by Application: 2022 VS 2029
Figure 9. Hospitals Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Online Pharmacies Case Studies
Figure 12. Cytomegalovirus Infection Report Years Considered
Figure 13. Global Cytomegalovirus Infection Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Cytomegalovirus Infection Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Cytomegalovirus Infection Market Share by Region: 2022 VS 2029
Figure 16. Global Cytomegalovirus Infection Market Share by Players in 2022
Figure 17. Global Top Cytomegalovirus Infection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cytomegalovirus Infection as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Cytomegalovirus Infection Revenue in 2022
Figure 19. North America Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Cytomegalovirus Infection Market Share by Country (2018-2029)
Figure 21. United States Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Cytomegalovirus Infection Market Share by Country (2018-2029)
Figure 25. Germany Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Cytomegalovirus Infection Market Share by Region (2018-2029)
Figure 33. China Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Cytomegalovirus Infection Market Share by Country (2018-2029)
Figure 41. Mexico Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Cytomegalovirus Infection Market Share by Country (2018-2029)
Figure 45. Turkey Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Roche Revenue Growth Rate in Cytomegalovirus Infection Business (2018-2023)
Figure 48. GlaxoSmithKline Revenue Growth Rate in Cytomegalovirus Infection Business (2018-2023)
Figure 49. Vical Revenue Growth Rate in Cytomegalovirus Infection Business (2018-2023)
Figure 50. AiCuris Anti-Infective Cures Revenue Growth Rate in Cytomegalovirus Infection Business (2018-2023)
Figure 51. ViroPharma Revenue Growth Rate in Cytomegalovirus Infection Business (2018-2023)
Figure 52. Chimerix Revenue Growth Rate in Cytomegalovirus Infection Business (2018-2023)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed